Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-gamma in oral cancer patients (Q40731919)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-gamma in oral cancer patients	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

title

Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-gamma in oral cancer patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

main subject

interleukins

0 references

lip and oral cavity carcinoma

1 reference

based on heuristic

inferred from title

author name string

K Yoneda

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

T Yamamoto

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

E Ueta

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

T Osaki

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

language of work or name

English

1 reference

based on heuristic

inferred from title

publication date

1 July 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

published in

Journal of Clinical Immunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

page(s)

289-299

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

cites work

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three schedules of recombinant human interleukin-2 in the treatment of malignancy: side effects and immunologic effects in relation to serum level

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of class II antigens by subsets of activated T cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous inhibitor of protein kinase C: association with human peripheral blood neutrophils but not with specific granule-deficient neutrophils or cytoplasts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of protein kinase C in neutrophil cytoplasts. Localization of protein substrates and possible relationship with stimulus-response coupling

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of intracellular calcium concentration and protein kinase C activation in IFN-gamma stimulation of U937 cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of combination therapy with interleukin 2 and beta-interferon in patients with advanced malignancy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1512302

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00918153

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

Dimensions Publication ID

1040146101

0 references

PubMed publication ID

1512302

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1512302

retrieved

23 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40731919&oldid=2203931524"